China Grand to fund Sirtex buy with rights issue

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

China Grand to fund Sirtex buy with rights issue

John Loh
July 06, 2018 06:15 am
Pills_230px

China Grand Pharmaceutical and Healthcare Holdings has opted to pay for its acquisition of Australia-listed Sirtex Medical with a HK$2.9bn ($370m) rights issue.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityChinaHong Kong SARAsia Follow-ons and Rights IssuesAsiaGreater ChinaNortheast AsiaAsia PacificFollow-ons and Rights issuesEmerging Markets
JL
John Loh
Gift this article